Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
Authors
Keywords
-
Journal
NUCLEIC ACIDS RESEARCH
Volume 49, Issue 16, Pages 9026-9041
Publisher
Oxford University Press (OUP)
Online
2021-08-20
DOI
10.1093/nar/gkab718
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOs
- (2021) Guillermo Vasquez et al. NUCLEIC ACIDS RESEARCH
- Antisense technology: an overview and prospectus
- (2021) Stanley T. Crooke et al. NATURE REVIEWS DRUG DISCOVERY
- Site-specific Incorporation of 2′,5′-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense Oligonucleotides
- (2021) Thazha P. Prakash et al. ACS Medicinal Chemistry Letters
- Mesyl Phosphoramidate Oligonucleotides as Potential Splice-Switching Agents: Impact of Backbone Structure on Activity and Intracellular Localization
- (2021) Suzan M. Hammond et al. Nucleic Acid Therapeutics
- Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for Proteins
- (2020) Malwina Hyjek-Składanowska et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phosphorothioate modified oligonucleotide–protein interactions
- (2020) Stanley T Crooke et al. NUCLEIC ACIDS RESEARCH
- Antisense Drug Discovery and Development Technology Considered in a Pharmacological Context
- (2020) Stanley T. Crooke et al. BIOCHEMICAL PHARMACOLOGY
- The Interaction of Phosphorothioate Containing RNA Targeted Drugs with Proteins is a Critical Determinant of The Therapeutic Effects of These Agents
- (2020) Stanley Crooke et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Investigating the pharmacodynamic durability of GalNAc–siRNA conjugates
- (2020) Christopher R Brown et al. NUCLEIC ACIDS RESEARCH
- Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency
- (2020) Olga A. Patutina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties
- (2019) S. K. Miroshnichenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective tissue targeting of synthetic nucleic acid drugs
- (2019) Punit P. Seth et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
- (2019) Wen Shen et al. NATURE BIOTECHNOLOGY
- Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins
- (2019) Michael T Migawa et al. NUCLEIC ACIDS RESEARCH
- RNases H: Structure and mechanism
- (2019) Malwina Hyjek et al. DNA REPAIR
- RNA-Targeted Therapeutics
- (2018) Stanley T. Crooke et al. Cell Metabolism
- Cellular uptake and trafficking of antisense oligonucleotides
- (2017) Stanley T Crooke et al. NATURE BIOTECHNOLOGY
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- New oligodeoxynucleotide derivatives containing N-(methanesulfonyl)-phosphoramidate (mesyl phosphoramidate) internucleotide group
- (2017) B. P. Chelobanov et al. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
- Fluorinated Nucleotide Modifications Modulate Allele Selectivity of SNP-Targeting Antisense Oligonucleotides
- (2017) Michael E. Østergaard et al. Molecular Therapy-Nucleic Acids
- Comprehensive Structure–Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes
- (2016) Thazha P. Prakash et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions
- (2016) Timothy A. Vickers et al. PLoS One
- Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
- (2015) Xue-hai Liang et al. NUCLEIC ACIDS RESEARCH
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- Structure and nuclease resistance of 2′,4′-constrained 2′-O-methoxyethyl (cMOE) and 2′-O-ethyl (cEt) modified DNAs
- (2012) Pradeep S. Pallan et al. CHEMICAL COMMUNICATIONS
- Synthesis and Biophysical Evaluation of 2′,4′-Constrained 2′O-Methoxyethyl and 2′,4′-Constrained 2′O-Ethyl Nucleic Acid Analogues
- (2010) Punit P. Seth et al. JOURNAL OF ORGANIC CHEMISTRY
- Solid-Phase Synthesis of Stereoregular Oligodeoxyribonucleoside Phosphorothioates Using Bicyclic Oxazaphospholidine Derivatives as Monomer Units
- (2008) Natsuhisa Oka et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started